| I-14 Hesham Al-Sallami The use of a Bayesian dosing tool to optimise enoxaparin treatment: a pilot clinical study Wednesday 09:50-11:15 |
| I-24 Geraldine Celliere Straightforward dose adaptation simulations with Simulx, the simulator of the MonolixSuite Wednesday 09:50-11:15 |
| I-34 Carla Bastida Fernández Assessment of tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients Wednesday 09:50-11:15 |
| I-49 Thomas Bouillon Model predictive control with Bayesian updates (MPC) is more robust to model misspecification, compared to standard Bayesian control (sEBE) for Therapeutic Drug Management (TDM). Investigation in a cohort of 315 patients receiving tacrolimus during the first 14d after renal transplantation. Wednesday 09:50-11:15 |
| I-62 Jantine Brussee Model-based dose optimization of ivermectin to achieve equivalent exposure coverage in children and adults Wednesday 09:50-11:15 |
| I-64 Dong Woo Chae Predictive model of postoperative nausea and vomiting in patients treated with Fentanyl-based intravenous patient controlled analgesia Wednesday 09:50-11:15 |
| I-67 Christophe Chassagnole A precision dosing application for docetaxel in metastatic prostate cancer Wednesday 09:50-11:15 |
| I-69 Jonathan Chauvin Novel user-friendly applications for dose individualization of sunitinib and imatinib Wednesday 09:50-11:15 |
| I-85 Laurence Del Frari Population modelling and simulations of binimetinib pharmacokinetics in subjects with hepatic impairment to explore optimal dosing regimen using total and unbound binimetinib exposures Wednesday 09:50-11:15 |
| II-16 Rory Leisegang Establishing evidence for improved outcomes for HIV+ patients receiving antiretroviral drugs through home delivery Wednesday 15:10-16:40 |
| II-32 Guangda Ma Evaluating the influence of genotype on warfarin dose predictions made using a theory-based PKPD model. Wednesday 15:10-16:40 |
| III-18 Christian Siebel Development of an adaptive dosing approach for doxorubicin in paediatric cancer patients Thursday 09:55-11:20 |
| III-21 Noppaket Singkham Pharmacogenetics-Based Population Pharmacokinetic Analysis for Dosing Optimization of Ritonavir-Boosted Atazanavir in Thai adult HIV-Infected Patients Thursday 09:55-11:20 |
| IV-03 Erwin Dreesen A population pharmacokinetic and exposure-response model to support therapeutic drug monitoring during vedolizumab induction therapy Thursday 15:25-16:50 |
| IV-39 Tingjie Guo Exploring practical limitations of model-based Bayesian dose optimization in intensive care patients Thursday 15:25-16:50 |
| IV-46 Emilie Hénin Therapeutic drug monitoring strategies for Envarsus in de novo renal transplant patients using population modelling and simulations Thursday 15:25-16:50 |
| IV-52 Nick Holford Rational dosing of caffeine using target concentration intervention to improve treatment of apnea of prematurity Thursday 15:25-16:50 |
| IV-79 Ron Keizer Continuous learning in model-informed precision dosing: a case study Thursday 15:25-16:50 |
